MedTrace Logo

Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant

NCT05695196 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-12-11

No results posted yet for this study

Summary

This feasibility and safety pilot study looks to determine whether transferring a parents healthy, diverse nasal microbiota to the participant's infant(s) will create a healthy, diverse neonatal nasal microbiome.

Conditions

  • Staphylococcus Aureus
  • Microbial Colonization
  • Neonatal Infection

Interventions

BIOLOGICAL

nasal microbiota transplant (NMT)

nasal microbiota transplant

BIOLOGICAL

Placebo

Placebo sterile saline

Sponsors & Collaborators

Principal Investigators

  • Aaron Milstone · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-25
Primary Completion
2025-05-06
Completion
2026-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05695196 on ClinicalTrials.gov